Kramer Robin bought BIIB
February 9, 2024 · Form 4 insider transaction
Kramer Robin bought 833 shares of Biogen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
833
Price
$0.00
Total value
N/A
InsiderKramer Robin
Role—
CompanyBiogen Inc. (BIIB)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 9, 2024
Filing dateFebruary 13, 2024
Shares owned after5,523
OwnershipDirect
10b5-1 planNo
AmendedNo